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1. Introduction 
Studying the interaction between protein protein- 
ase inhibitors and their target enzymes by physico- 
chemical methods has often been hampered by the 
lack of suitable intrinsic spectroscopic signals, which 
change upon complex formation. 
specifically spin-labelled at the amino-terminus and 
its complexes with trypsin, chymotrypsin and trypsin- 
ogen were chosen as a first test system. 
2. Experimental 
2.1. Materials 
One approach to circumvent this difficulty is to 
introduce an indirect signal by coupling an indicator 
reaction to the reaction of interest. Examples are 
monitoring the enzymatic activity of free enzyme [2] 
or following the displacement of proflavin from the 
enzyme when the inhibitor is bound [3]. With all 
these indirect measurements careful studies as to pos- 
sible side reactions and influences on the equilibrium 
and kinetic properties of the enzyme/inhibitor system 
have to be included. Another approach is to covalently 
attach reporter groups to the reaction partners. The 
association of chymotrypsin and the bovine trypsin 
inhibitor (Kunitz) for example was studied using 
covalently bound fluorescent labels [4]. Employing 
these techniques always comprises to show that the 
reporter groups are tolerable perturbations of the 
system under investigation. 
Bovine trypsin (EC 3.4.21.4), chymotrypsin (EC 
3.4.21 .l) and trypsinogen were obtained from Merck 
(Darmstadt). 3.Maleimido-2,2,5,5_tetramethylpyr- 
rolidine-I -oxyl was purchased from Syva (Palo Alto 
CA). The bovine trypsin inhibitor (Kunitz), Trasylol@, 
was kindly provided by Bayer (Wuppertal). 
2.2. Enzymatic assays 
Enzyme activities were measured spectropho- 
tometrically using N-benzoyl-L-arginine4-nitroanilide 
as substrate for trypsin and N(3carboxypropionyl)- 
L-phenylalanine4-nitroanilide as substrate for chymo- 
trypsin [6]. 
2.3. Guanidination 
Covalently attached nitroxyl radicals or spin-labels 
have been frequently used to monitor events in bio- 
logical systems on the molecular level [5]. This paper 
examines the potentials of the spin-label method as a 
new tool to study the interaction between proteinases 
and their protein inhibitors. The fully guanidinated 
bovine trypsin inhibitor (Kunitz), which could be 
Guanidination of the native inhibitor with O-meth- 
ylisourea was carried out essentially as in [7]. Amino 
acid analysis indicated quantitative conversion of all 
4 lysine residues to homoarginine residues. 
2.4. Spin-labelling 
Presented in part at the Jahrestagung der Deutschen Gesell- 
schaft fiir Biophysik in Hannover, 1981 (11 
Guanidinated inhibitor, 10.6 mg (1.6 pmol), and 
3-maleimido-2,2,5,5-tetramethylpyrrolidine-1 oxyl, 
3.6 mg (15 pmol), in 0.5 ml 50 mM phosphate buffer 
(pH 7.4) were shaken at room temperature for 140 h. 
Insoluble material was separated by centrifugation 
and the supematant passed through a column of 
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Sephadex G-25 fine (1.4 X 100 cm) equilibrated with 
10 mM ammonium acetate. The fractions containing 
protein were pooled, lyophilized, dissolved in water 
and lyophilized again. Amino acid analysis of the 
product showed 5 .16 arginine residues compared to 
6 of the native inhibitor. 
2.5 . ESR measurements 
All ESR experiments were carried out on a Varian 
E-l 2 X-band spectrometer atambient emperature. 
The instrument settings were: scan range 10 mT, 
modulation amplitude 0.2 mT, microwave power 
50 mW, time constant 0.3 s, scan time 4 min. Sealed 
disposable micropipettes of 50 ,ul or 100 fl content 
(Brand, Wertheim) were used as sample cells. The 
buffer was 0.1 M triethanolamine-HCl (pH 7.0). ESR 
titrations were carried out at constant otal concen- 
tration sf spin-labelled inhibitor, varying the enzyme 
concentration. The ratio (Y = [inhibitor&+J[inhib- 
itorltoti for a given enzyme concentration was cal- 
culated from the amplitude A of the low field line: 
(Y = (A -A,)/(_4 o-A,). A 0 and A, are the amplitudes 
at zero enzyme concentration and at an excess enzyme 
concentration sufficient o bring about virtually com- 
plete complex formation. Rotational correlation times 
were estimated as in [8] assuming isotropic motion. 
Dissociation constants were determined as in [9] or 
3 .l . Guanidination and spin-labelling 
The bovine trypsin inhibitor (Kunitz) was guani- 
dinated with O-methylisourea [7]. Quantitative 
amino acid analysis revealed that the conversion of all 
4 lysine residues, including the reactive site lysine-15, 
to homoarginine r sidues was complete. The &amino 
group of arginine-1 remained unaffected and lent 
itself as the attachment point for the nitroxyl moiety. 
We chose 3-maleimido-2,2,5,5 -tetramethylpyrrolidine- 
1-oxyl as spin-label reagent, because maleimides are 
known to react rather specifically with amino groups 
provided that no sulfhydryl groups are present [111. 
Quantitative valuation of the ESR spectrum (double 
integration and comparison with a standard solution) 
showed the incorporation of 0.87 nitroxyl groups/ 
inhibitor molecule, a value in agreement with the loss 
of 0.84 arginine residues found by amino acid analy- 
sis. These figures indicate an almost complete spin- 
labelling of the inhibitor exclusively at its amino ter- 
minus. 
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3.2. Inhibitory activities 
The inhibition curves in fig.1 show that the bovine 
inhibitor and its guanidinated and spin-labelled deriv- 
atives exhibit virtually the same specific inhibitory 
activities when tested against trypsin or chymotrypsin. 
The 1: 1 stoichiometries remain unaffected by the 
derivatisations. From fig.lb it can be concluded that 
the dissociation constants for the 3 chymotrypsin 
complexes are -70 nM. Because of the extremely 
weak dissociation of the trypsin complexes evident 
from fig.la an estimation of the corresponding con- 
stants is not possible. 
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Fig.1. Inhibition of bovine trypsin (a) and bovine chymo- 
trypsin (b) by the native (o), guanicmated (0) and the spin- 
labelled guanidinated (A) bovine trypsin inhibitor (Kunitz) 
(pH 7.8). Trypsin was 0.16 NM and chymotrypsin 0.8 PM; 
inhibitor concentrations varied. 
Volume 140, number 1 FEBS LETTERS April 1982 
3.3. ESR spectra 
The spin-labelled guanidinated inhibitor in solu- 
tion shows a ‘weakly immobilized’ ESR spectrum 
(fig.2a). Assuming isotropic motion, the rotational 
correlation time 7C of the spin-label can be estimated 
to be -2 ns [S], from which a particle diameter d of 
-2.5 nm can be calculated, when the simple Debye 
model of rotation is used: TV = w3/6 kT. Taking 
into account he geometry of the inhibitor, which is a 
pear-shaped molecule with a greatest length of 2.9 nm 
and a greatest diameter of 1.9 nm [ 121, this would 
seem to suggest that the nitroxyl group has only 
rather limited mobility relative to the protein. 
When increasing amounts of trypsin, chymotrypsin 
or trypsinogen are added to the inhibitor solution, 
the ESR lines become broader and their amplitudes 
decrease. With complete complex formation a rota- 
tional correlation time of -5 ns can be determined 
from the corresponding spectrum. These spectral 
changes are exemplified in fig.2 by a series of ESR 
spectra resulting from a chymotrypsin titration. The 
appearance of several isoclinic points suggests he 
existence of an equilibrium between 2 populations of 
spin-labels [ 131, one attached to free inhibitor and 
the second attached to the enzyme/inhibitor complex. 
3.4. Complexes with proteinases 
The fraction of free inhibitor at each point of a 
titration can be calculated from the ESR amplitudes 
(see section 2). The low field line was chosen, because 
1 mT I . 
it experiences the greatest changes. Fig.3 shows the 
resulting ESR titration curves with trypsin and 
chymotrypsin. A 1: 1 stoichiometry is evident for 
both proteinase/inhibitor complexes. The dissociation 
constant for the chymotrypsin/spin-labelled guani- 
dinated inhibitor complex can be estimated from the 
non-linear part of the curve to be -80 nM. This value 
is in the same order of magnitude as the dissociation 
constant of 11 nM determined by kinetic measure- 
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Fig.2. ESR spectra showing a titration of sph&beIled guani- 
dinated inhibitor with bovine chymotxypti (pH 7.0). Inhibitor 
was 50 PM. Chymotrypsin concentrations: (a) 0 NM; (b) 
20 PM; (c) 40 PM; (d) 60 PM. 
Fig.3. ESR titration curves of spin&belied guanidinated 
inhibitor with bovine trypsin (a) and bovine chymotrypsin 
(b) @H 7.0). Inhibitor was 50 MM; enzyme concentrations 
varied. 
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ments at pH 8 .O for the complex of chymotrypsin 
and Kunitz inhibitor specifically guanidinated at 
lysine-15 [14]. 
3 5. Complexes with ttypsinogen 
Trypsinogen is known to form a relatively weak 
1: 1 complex with the bovine trypsin inhibitor (Kd 
2 pM at pH 8.0) [ 15 ,161. ESR titration of spin-labelled 
guanidinated inhibitor with trypsinogen also indicates 
a 1: 1 complex (Kd 20 @I at pH 7.0). The binding 
can be significantly enhanced by addition of the 
dipeptide Ile-Val. The reduction of the ESR ampli- 
tude at 50 PM trypsinogen and 50 &I inhibitor con- 
centration upon addition of 5 mM Ile-Val corre- 
sponds to a decrease of the dissociation constant to 
-7 /.&I. 
The dipeptides Met-Val, Leu-Val, Ala-Val and 
Ala-Ala are without any appreciable effect. Thus, 
proenzyme, inhibitor and Ile-Val specifically form a 
ternary complex. 
This result corroborates the detailed studies on 
the mechanism of trypsinogen activation [ 16,171. 
The activation is brought about by the enzymatic 
removal of the N-terminal hexapeptide followed by 
the binding of the newly formed a-amino group of 
Ile-16 to the carboxylate side chain of Asp-l 94. This 
interaction is of crucial importance for the stability 
and function of the active trypsin. The dipeptide 
Ile-Val can play the structural role of the N-terminus 
of the active enzyme and introduce a transition of 
trypsinogen to a trypsin-like state. This reveals itself 
in the enhanced binding of the spin-labelled guani- 
dinated inhibitor. 
4. Lkcussion 
This paper introduces spin-labelling in combina- 
tion with ESR spectroscopy as a new and promising 
tool to study the interaction between proteinases 
and their protein inhibitors. A maleimide spin-label 
was rather rigidly attached to the terminal amino- 
group of the guanidinated bovine trypsin inhibitor 
(Kunitz), where it did not appreciably change the 
specific inhibitory activity. The paramagnetic nitroxyl 
moiety provided ESR signals, which allowed for 
direct quantitative monitoring of the complex forma- 
tion between inhibitor and trypsin, chymotrypsin or 
trypsinogen. A 1: 1 stoichiometry was found in all 
cases, the dissociation constants were somewhat 
increased as compared with the unlabelled systems. 
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The high sensitivity of the ESR technique makes it 
possible to detect reasonable signals even ir_r -10 4 of 
a m spin-label solution. The signal-to-noise ratio can 
certainly be improved by the use of spectral accumu- 
lation and other recent technical advances. Other 
attractive aspects of the spin-label method are the 
possibility to measure in optically opaque solutions 
and, usually, the absence of interfering signals from 
the environment. 
The inherent disadvantage of spin-labelling, which 
it has in common with any reporter group technique, 
is the perturbation of the system by the addition of 
the reporter molecule. However, with the broad selec- 
tion of spin-labels now available with specificities for 
distinct amino acid side chains it should be feasible 
to minimize this problem. Thus it can be anticipated 
that our spin-label approach may be an additional 
useful tool also for other studies of protein/protein 
association. 
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